مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas.
Normal view MARC view ISBD view

The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas. [electronic resource]

By:
  • Juratli, T A
Contributor(s):
  • Kirsch, M
  • Geiger, K
  • Klink, B
  • Leipnitz, E
  • Pinzer, T
  • Soucek, S
  • Schrock, E
  • Schrok, E
  • Schackert, G
  • Krex, D
Producer: 20130423Description: 325-33 p. digitalISSN:
  • 1573-7373
Subject(s):
  • Adult
  • Aged
  • Biomarkers, Tumor -- genetics
  • Brain Neoplasms -- genetics
  • Chromosome Deletion
  • Chromosomes, Human, Pair 1 -- genetics
  • Chromosomes, Human, Pair 19 -- genetics
  • DNA Methylation
  • DNA Modification Methylases -- genetics
  • DNA Repair Enzymes -- genetics
  • DNA, Neoplasm
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Glioblastoma -- genetics
  • Humans
  • Isocitrate Dehydrogenase -- genetics
  • Male
  • Middle Aged
  • Mutation -- genetics
  • Neoplasm Grading
  • Polymerase Chain Reaction
  • Prognosis
  • Promoter Regions, Genetic -- genetics
  • Survival Rate
  • Tumor Suppressor Proteins -- genetics
  • Young Adult
Online resources:
  • Available from publisher's website
In: Journal of neuro-oncology vol. 110
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.

The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas.

APA

Juratli T. A., Kirsch M., Geiger K., Klink B., Leipnitz E., Pinzer T., Soucek S., Schrock E., Schrok E., Schackert G. & Krex D. (20130423). The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas. : Journal of neuro-oncology.

Chicago

Juratli T A, Kirsch M, Geiger K, Klink B, Leipnitz E, Pinzer T, Soucek S, Schrock E, Schrok E, Schackert G and Krex D. 20130423. The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas. : Journal of neuro-oncology.

Harvard

Juratli T. A., Kirsch M., Geiger K., Klink B., Leipnitz E., Pinzer T., Soucek S., Schrock E., Schrok E., Schackert G. and Krex D. (20130423). The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas. : Journal of neuro-oncology.

MLA

Juratli T A, Kirsch M, Geiger K, Klink B, Leipnitz E, Pinzer T, Soucek S, Schrock E, Schrok E, Schackert G and Krex D. The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas. : Journal of neuro-oncology. 20130423.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site